News
The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...
13h
Health and Me on MSNPopular Supplements 'Used By Millions' Linked To Surge In Liver Failure: Is Your Nutritional Label Hiding Deadly Risks?Over 15 million Americans consume popular herbal supplements like turmeric and green tea extract, yet studies reveal these ...
17h
Mashed on MSNThe Biggest Cake Recalls In US HistoryCake typically marks celebrations, but none of these cake recalls were cause for festivity. Learn about the biggest cake ...
FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...
Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
Dozens of prepared foods, vegetable plates and sushi are being recalled for containing cucumbers linked to 26 cases of ...
LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...
Health officials are reviewing a dubious report that claims dangerous complications from mifepristone. Public health ...
Axsome Therapeutics (NASDAQ: AXSM), and Summit Therapeutics (NASDAQ: SMMT). (Alnylam Pharmaceuticals): In her comments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results